middle.news
Island Pharmaceuticals Boosts Galidesivir Supply to 800 Courses Amid Escalating Ebola Outbreak
8:56am on Friday 21st of August, 2026 AEST
•
Pharmaceuticals
Read Story
Island Pharmaceuticals Boosts Galidesivir Supply to 800 Courses Amid Escalating Ebola Outbreak
8:56am on Friday 21st of August, 2026 AEST
Key Points
Second GMP manufacturing campaign underway with PI Health Sciences
Inventory to reach 700–800 treatment courses by Q4 2026
Supports WHO-approved compassionate use in Uganda outbreak
Galidesivir shows strong efficacy in non-human primate Ebola and Marburg models
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE